Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session on Indian Patient Experience on Adalimumab
Adalimumab, a widely used biologic for treating various autoimmune conditions, has garnered positive feedback from Indian patients for its efficacy in managing diseases such as rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Patients report significant improvements in symptom relief, including reduced pain, swelling, and skin lesions, leading to enhanced quality of life. This biologic’s ability to provide rapid and sustained symptom control has been particularly appreciated, allowing patients to regain mobility and participate more actively in daily activities.
However, the high cost of adalimumab remains a significant barrier for many Indian patients, limiting its accessibility despite its proven benefits. To address this issue, the introduction of biosimilars has provided a more affordable alternative, increasing the number of patients who can benefit from this treatment. Patients using biosimilar versions have reported similar therapeutic outcomes, making these options a valuable addition to the treatment landscape in India.
Therefore, get an overall knowledge of indian patient experience on adalimumab
See More Webinars @ Hidoc Webinars
1.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
2.
New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.
3.
Research finds stark disparities in treatment and survival time for people with pancreatic cancer
4.
Tumor characteristics found to differ for melanomas in children, teens and young adults
5.
Relationship-building key to addressing oncologist shortages in rural care
1.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
2.
Colon cancer: Risk factors, warning signs and treatment options
3.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
4.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation